Pillstats
Rx only · Injection, Solution · Epidural

Bupivacaine Hydrochloride And Epinephrine Bitartrate

Brands: Marcaine With Epinephrine · Sensorcaine Mpf · Bupivacaine Hydrochloride + Epinephrine Bitartrate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3992
US makers3 labelers
Packages13
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.1K4.1K6.2K8.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.6K
Rx · 2026 Q1
147K
Units dispensed
-35%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown8SUPPLYING
Hospira, Inc.unknown4SUPPLYING
Henry Schein Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 10, 2020
    RECALLRecall (Class II): Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Do…

    Subpotent Drug: Low out-of-specification assay results for the epinephrine component. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide in the USA

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Fresenius Kabi USA, LLC)

    Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia.

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (Fresenius Kabi USA, LLC)

    Bupivacaine Hydrochloride Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia.